A clinical trial:To study the effect of Ayurvedic herbal drug in pelvic inflammatory diseases

Phase 2

Conditions: Health Condition 1: null- Married patients of active reproductive life (age 21-45 years) having symptoms and associated symptoms related with PID and also diagnosed to have PID for the preceeding 6-12 months

Registration Number: CTRI/2018/04/013042

Lead Sponsor: Banaras Hindu University

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1.Patients who are willing to participate in present study after giving the proper consent.

2.Patient is married.

3.Patient having complain of lower abdominal pain, unusual vaginal discharges, pain during coitus, menstrual disorders, fever, associated symptoms related with PID and also diagnosed to have PID for the preceeding 6-12 months

Exclusion Criteria

1.Patient is unmarried.

2.Patient is pregnant.

3.Patient suffering from any systemic disease like tuberculosis, diabetes mellitus, bronchial asthma, jaundice, cardiovascular disease, any renal problem.

4.Patient having any infection like TORCH, HIV, Hepatitis etc.

5.Patient having any drug allergy and psychological disorders.

6.Patient having any specific pathology of genital tract ie benign or malignant tumor, tubo-ovarian abscess, erosion of the cervix etc.

7.Patient suffering from any disease on external genital organs like any boil, infected cyst, bartholian gland abscess or any skin disease i.e. eczema, vulvo-vaginitis etc.

8.Patient with history of more than three episodes of PID.

9.Patient can not attend follow up regularly.

10.Patient not giving consent to participation in the study.

11.Patient who is participating in any research study.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complains- lower abdominal pain, Pain during coitus with intensity of pain, unusual vaginal discharges, menstrual irregularities, fever <br/ ><br>sign- lower abdominal tenderness,cervical motion tenderness, fornices tenderness and adenexal tenderness and raised C-RP <br/ ><br>Investigation- USG of pelvic organ and adenexaTimepoint: Total five follow up will be done at a regular interval of 15 days. four follow up with medication and fifth follow up without medication.

Secondary Outcome Measures